DENGUE EARLY ANTIGEN (NS1 ANTIGEN), SERUM

Dengue Early Antigen (NS1 Antigen), Serum

What it is

The Dengue Early Antigen (NS1 Antigen), Serum test is a diagnostic test that detects the presence of the non-structural protein 1 (NS1) of the dengue virus in the blood. NS1 is released into the bloodstream during the early phase of infection, usually within the first 1–7 days of fever, making this test one of the earliest markers of acute dengue infection.

Uses

This test is primarily used for the early diagnosis of dengue fever. It helps doctors confirm dengue infection before the body produces detectable levels of antibodies (IgM/IgG). Early detection is crucial for monitoring patients at risk of severe dengue complications and guiding supportive care to reduce hospitalization risk.

Symptoms That May Lead to the Test

Doctors may order this test if you have acute symptoms such as sudden high fever, severe headache, pain behind the eyes, muscle and joint pain, nausea, vomiting, skin rash, or mild bleeding (e.g., gum or nose bleeds). It is especially useful in patients living in or returning from dengue-endemic areas.

Abnormal Results

Positive NS1 Antigen: Confirms an active dengue infection in its early phase. It helps distinguish dengue from other febrile illnesses such as malaria, chikungunya, or influenza.

Negative NS1 Antigen: Suggests no dengue antigen detected. However, a negative result does not completely rule out dengue, especially if testing is done late in the illness. Additional tests like dengue IgM/IgG antibodies or PCR may be recommended.

Risks

The test requires a standard blood sample. Risks are minimal and limited to mild discomfort, bruising, or dizziness at the puncture site. These effects are temporary and usually resolve quickly.